Improvement of migraine using CGRP mAbs in a real-world setting Presented ByProf. Robert E. Shapiro, University of Vermont, VT, USA TrialOVERCOME ConferenceMTIS 2020 27 October, 2020 15:47
Concomitant preventive medication has no impact on efficacy of ubrogepant Presented ByDr Andrew M. Blumenfeld, Headache Center of Southern California, USA TrialPhase 3, ACHIEVE I and II ConferenceMTIS 2020 27 October, 2020 15:36
Real-world evidence reveals physicians’ perception of erenumab Presented ByDr Mirja Koch, Clinical Research Neuroscience, Novartis Pharma GmbH, Germany TrialTELESCOPE ConferenceMTIS 2020 27 October, 2020 15:14
Fremanezumab effective in patients with migraine and comorbid depression Presented ByProf. Dawn C. Buse, Albert Einstein College of Medicine, NY, USA TrialPhase 3, FOCUS, HALO ConferenceMTIS 2020 27 October, 2020 15:08
Sustained shift in migraine status using galcanezumab Presented ByDr William S. Kingston, Sunnybrook Health Sciences Centre, Canada TrialPhase 3, CONQUER ConferenceMTIS 2020 27 October, 2020 14:35
Long-term efficacy and safety of fremanezumab in treatment-resistant migraine Presented ByDr M. Ashina TrialPhase 3, FOCUS ConferenceMTIS 2020 27 October, 2020 14:31
